Preferred Forms
- 200 _ | ‡a Toth ‡b Peter P.
-
- 100 1 _ ‡a Toth, Peter P.
-
-
- 100 1 _ ‡a Toth, Peter P.
-
-
- 100 1 _ ‡a Toth, Peter P.
-
-
- 100 1 _ ‡a Tóth, Peter P.
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
ASPC Manual of Preventive Cardiology | |
Clinical challenges in hypertension II | |
Comprehensive cardiovascular medicine in the primary care setting | |
Comprehensive management of high risk cardiovascular patients | |
Czy powinniśmy wpływać na stężenie cholesterolu HDL w celu zmniejszenia ryzyka sercowo-naczyniowego? | |
The family practice handbook, c1997: | |
High-density lipoprotein: epidemiology, metabolism, and antiatherogenic effects | |
Leczenie dużymi dawkami statyn : korzyści i bezpieczeństwo intensywnej terapii hipolipemizującej | |
Leczenie dużymi dawkami statyn / Peter P. Toth, Michael H. Davidson. Komentarz | |
Lipid lowering nutraceuticals in clinical practice : position paper from an International Lipid Expert Panel | |
Lipoproteins in diabetes mellitus | |
Modern prevalence of the Fredrickson-Levy-Lees dyslipidemias : findings from the Very Large Database of Lipids and National Health and Nutrition Examination Survey | |
Molecular mechanisms of statin intolerance | |
Natural approaches in metabolic syndrome management | |
Practical lipid management : concepts and controversies | |
Should we target HDL cholesterol level in lowering cardiovascular risk? | |
Therapeutic lipidology | |
An urgent matter : identifying your patients' cardiovascular risk and improving their outcomes |